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A 23-year-old female patient presented to the Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, 
California, in 2016 with a two-month history of prog-
ressive swelling and pain of the upper and lower jaws 
and palate, drooling, lisping and difficulty chewing and 
swallowing. She had undergone a bilateral nephrectomy 
due to a bilateral Wilms’ tumour 22 years prior at 14 
months of age. She then received haemodialysis until 
she was six years old, at which time she received a kidney 
transplant. However, the transplanted kidney failed due 
to medication noncompliance and she subsequently 
resumed haemodialysis at the age of 16 years. She had 
secondary hyperparathyroidism and was noncompliant 
with medications to control the disorder. She also had 
congestive heart failure and cryptogenic organising 
pneumonia requiring home oxygen therapy. She had 
no family history of hyperparathyroidism. 
A physical examination revealed maxillary and 
mandibular swelling, tenderness and wide interdental 
spacing. Before haemodialysis, the patient’s parathyroid 
hormone level was >1,700 pg/mL (normal range: 
11–51 pg/mL), total calcium level was 10.3 mg/dL 
(normal range: 8.6–10.3 mg/dL), ionised calcium level 
was 1.09 mmol/L (normal range: 1.09–1.29 mmol/L), 
phosphorus level was 7.3 mg/dL (normal range: 
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Figure 1: Three-dimensional reconstructions of the (A) facial features and (B) bones of a 23-year-old female with 
uremic leontiasis ossea based on non-contrast sinus computed tomography of the (C) mandible and (D) maxilla.
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The term ULO is derived from the appearance of 
the facial deformity due to bony overgrowth around 
the oral cavity which resembles the face of a lion. 
Radiographically, ULO manifests as hypertrophy and 
hyperostosis of the facial bones and calvaria, especially 
the maxilla and mandible, and diffuse mixed sclerotic 
and lytic changes best illustrated by non-contrast CT.2–5 
The reason as to why the facial bones and calvaria are 
selectively affected in ULO cases is not clear. In the 
current case, the affected patient had all of the typical 
clinical, laboratory and radiographical features of ULO.
If left untreated, patients with ULO may develop 
severe disfigurement, dysphagia, speech impairment, 
respiratory distress and blindness.2–4 The management 
of ULO cases should focus on controlling secondary or 
tertiary hyperparathyroidism, either with medication 
or surgically with a parathyroidectomy.3 Unfortunately, 
surgical resection was not feasible in the current case 
and the patient did not adhere to prescribed medical 
therapy. As such, there was no evidence of clinical 
improvement at a one-month follow-up appointment.
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2.3–4.4 mg/dL), 25-hydroxyvitamin D level was 
16 ng/mL (normal range: 20–50 ng/mL) and serum 
alkaline phosphatase level was 1,610 U/L (normal 
range: 37–113 U/L).
Three-dimensional reconstructions and axial 
non-contrast sinus computed tomography (CT) scans 
showed deformities of the mouth and nose, gross 
expansion of the mandible, maxilla and calvaria, 
overbite and overjet, diffuse mixed sclerotic and lytic 
changes to all visualised osseous structures and 
regions of focal lytic expansion in the mandible and 
maxilla [Figure 1]. Subsequently, the patient was 
diagnosed with uremic leontiasis ossea (ULO). Due to 
her significant cardiopulmonary comorbidities and 
high perioperative risk, a parathyroidectomy was not 
possible. The patient was advised to resume medical 
therapy with cinacalcet, calcitriol and sevelamer. How-
ever, one month later, the patient was found to be only 
intermittently compliant with these medications and 
did not exhibit significant clinical improvement.
Comment
Chronic kidney disease-associated mineral and bone 
disorders (CKD-MBDs), previously termed renal osteo- 
dystrophy, include hormonal abnormalities such as 
secondary hyperparathyroidism, deranged bone turn-
over and mineralisation and extraskeletal calcification.1 
Also known as maxillary hyperplasia and hyperostosis 
cranialis, ULO is the rarest and most severe form of 
CKD-MBDs; it usually occurs in young adults with long-
standing chronic renal failure and poorly controlled 
secondary or tertiary hyperparathyroidism, as in the 
current case.2–4 While the specific pathogenesis of ULO 
is unknown, deranged bone turnover and minerali-
sation caused by poorly controlled secondary hyper-
parathyroidism is likely a key feature.2 
